Noninvasively evaluating the grading and IDH1 mutation status of diffuse gliomas by three-dimensional pseudo-continuous arterial spin labeling and diffusion-weighted imaging
- 18 May 2018
- journal article
- research article
- Published by Springer Nature in Neuroradiology
- Vol. 60 (7) , 693-702
Abstract
To noninvasively evaluate the value of three-dimensional pseudo-continuous arterial spin labeling (3D pCASL) and diffusion-weighted imaging (DWI) in diffuse gliomas grading as well as isocitrate dehydrogenase (IDH) 1 mutation status.Keywords
Funding Information
- National Natural Science Foundation of China (81372457)
This publication has 50 references indexed in Scilit:
- Non-invasive in vivo assessment of IDH1 mutational status in gliomaNature Communications, 2013
- Control of Voltage-gated Potassium Channel Kv2.2 Expression by Pyruvate-Isocitrate Cycling Regulates Glucose-stimulated Insulin SecretionJournal of Biological Chemistry, 2013
- Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patientsCancer Science, 2012
- Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imagingNeuroradiology, 2009
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in GliomasJournal of Clinical Oncology, 2009
- IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomasNeuro-Oncology, 2009
- Lactate promotes glioma migration by TGF-β2–dependent regulation of matrix metalloproteinase-2Neuro-Oncology, 2009
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αScience, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007